Ingvar Rydén

Publications

2024

Carlos Oltmanns, Birgit Bremer, Laura Kusche, Per Stål, Robin Zenlander, Jan Tauwaldt, Ingvar Rydén, Peter Påhlsson, Markus Cornberg, Heiner Wedemeyer (2024) Elevation of S2-bound a1-acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma Journal of Viral Hepatitis, Vol. 31, p. 383-390 (Article in journal) https://dx.doi.org/10.1111/jvh.13943

2023

Viktor Hultqvist, Jonas Bonnedahl, Jonathan Edwardsson, Ivar Tjernberg, Ingvar Rydén (2023) High seroprevalence of SARS-CoV-2 antibodies in healthcare workers in COVID-19 wards indicates an occupational hazard-a prospective cohort study during the first year of the COVID-19 pandemic in Kalmar County, Sweden Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), Vol. 131, p. 491-497 (Article in journal) https://dx.doi.org/10.1111/apm.13343

Robin Zenlander, Claudia Fredolini, Jochen M. Schwenk, Ingvar Rydén, Peter Påhlsson, Christian Loewbeer, Gosta Eggertsen, Per Stal (2023) A wide scan of plasma proteins demonstrates thioredoxin reductase 1 as a potential new diagnostic biomarker for hepatocellular carcinoma Scandinavian Journal of Gastroenterology, Vol. 58, p. 998-1008 (Article in journal) https://dx.doi.org/10.1080/00365521.2023.2194008

Per H. Nilsson, Mahmoud Al-Majdoub, Ahmed Ibrahim, Obaidullah Aseel, Subramanian Suriyanarayanan, Linnea Andersson, Samir Fostock, Teodor Aastrup, Ivar Tjernberg, Ingvar Rydén, Ian A. Nicholls (2023) Quartz Crystal Microbalance Platform for SARS-CoV-2 Immuno-Diagnostics International Journal of Molecular Sciences, Vol. 24, Article 16705 (Article in journal) https://dx.doi.org/10.3390/ijms242316705

Patrik Nasr, Mikael Forsgren, Wile Balkhed, Cecilia Jönsson, Nils Dahlström, Christian Simonsson, Shan Cai, Anna Cederborg, Martin Henriksson, Henrik Stjernman, Martin Rejler, Daniel Sjoegren, Gunnar Cedersund, Wolf Bartholomä, Ingvar Rydén, Peter Lundberg, Stergios Kechagias, Olof Dahlqvist Leinhard, Mattias Ekstedt (2023) A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol BMC Gastroenterology, Vol. 23, Article 454 (Article in journal) https://dx.doi.org/10.1186/s12876-023-03093-8